We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$9.85B
AUM Growth
+$544M
Cap. Flow
+$305M
Cap. Flow %
3.1%
Top 10 Hldgs %
10.6%
Holding
1,507
New
131
Increased
296
Reduced
233
Closed
100

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$70.2M
2
SRE icon
Sempra
SRE
+$62.5M
3
LNC icon
Lincoln National
LNC
+$62.2M
4
XL
XL Group Ltd.
XL
+$60.6M
5
NEE icon
NextEra Energy
NEE
+$58.5M

Sector Composition

Rank Sector Weight
1 Financials 23.55%
2 Industrials 12.89%
3 Consumer Discretionary 12.47%
4 Healthcare 10.29%
5 Technology 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHIIK
801
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$1.22M 0.01%
119,750
CLAR icon
802
Clarus
CLAR
$123M
$1.21M 0.01%
147,854
-42,507
-22% -$306K
DSPG
803
DELISTED
DSP Group Inc
DSPG
$1.21M 0.01%
97,300
RAIL icon
804
FreightCar America
RAIL
$261M
$1.21M 0.01%
72,081
RMAX icon
805
RE/MAX Holdings
RMAX
$193M
$1.21M 0.01%
23,068
STRR
806
DELISTED
Star Equity Holdings
STRR
$1.21M 0.01%
15,614
+520
+3% +$41.6K
FLXS icon
807
Flexsteel Industries
FLXS
$302M
$1.21M 0.01%
30,300
+6,000
+25% +$231K
VSTM icon
808
Verastem
VSTM
$510M
$1.21M 0.01%
14,633
-4,384
-23% -$268K
NERV icon
809
Minerva Neurosciences
NERV
$185M
$1.2M 0.01%
18,150
ASNA
810
DELISTED
Ascena Retail Group, Inc.
ASNA
$1.2M 0.01%
+15,000
New +$907K
AXAS
811
DELISTED
Abraxas Petroleum Corp
AXAS
$1.19M 0.01%
+20,615
New +$1.12M
HIL
812
DELISTED
Hill International, Inc. Common Stock
HIL
$1.19M 0.01%
201,551
PIR
813
DELISTED
Pier 1 Imports, Inc.
PIR
$1.19M 0.01%
24,975
QHC
814
DELISTED
Quorum Health Corporation
QHC
$1.19M 0.01%
237,200
+55,000
+30% +$353K
BCBP icon
815
BCB Bancorp
BCBP
$173M
$1.18M 0.01%
78,712
CMT icon
816
Core Molding Technologies
CMT
$202M
$1.18M 0.01%
82,500
-3,000
-4% -$46.2K
PHLT
817
DELISTED
Performant Healthcare Inc
PHLT
$1.17M 0.01%
546,200
RDI icon
818
Reading International Class A
RDI
$33.2M
$1.17M 0.01%
73,348
EPE
819
DELISTED
EP Energy Corporation
EPE
$1.17M 0.01%
390,000
-455,000
-54% -$1.08M
LEAF
820
DELISTED
Leaf Group Ltd.
LEAF
$1.17M 0.01%
107,600
CXDC
821
DELISTED
China XD Plastics Company Limited
CXDC
$1.16M 0.01%
358,300
AXTI icon
822
AXT Inc
AXTI
$3.95B
$1.16M 0.01%
164,906
TTOO
823
DELISTED
T2 Biosystems, Inc
TTOO
$1.16M 0.01%
30
CDZI icon
824
Cadiz
CDZI
$251M
$1.16M 0.01%
88,200
NAII icon
825
Natural Alternatives International
NAII
$14.4M
$1.16M 0.01%
113,810

Similar funds

Bridgeway Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Bridgeway Capital Management held 1,507 positions worth $9.85B, up 5.8% from $9.31B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bridgeway Capital Management deployed $305M of net new capital in Q2 2018, opening 131 new positions and adding to 296 existing holdings. Its largest new stake was Morgan Stanley: 1,333,400 shares worth $63.2M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Lam Research, an estimated $70.2M trimmed.

  • Bridgeway Capital Management's largest Q2 2018 buy was Morgan Stanley: 1,333,400 shares worth $63.2M.
  • Bridgeway Capital Management added most to Cigna in Q2 2018, an estimated $58.3M increase.
  • Bridgeway Capital Management's biggest Q2 2018 reduction was Lam Research, cutting an estimated $70.2M.
  • Bridgeway Capital Management fully exited Sempra in Q2 2018, selling an estimated $62.5M.
  • Bridgeway Capital Management's ten largest holdings make up 11% of its $9.85B portfolio in Q2 2018.
  • Bridgeway Capital Management opened 131 new positions and closed 100 in Q2 2018.
  • Bridgeway Capital Management's portfolio value rose 5.8% quarter-over-quarter to $9.85B.

Based on Bridgeway Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.